CAPP Medical Overview
- Latest Deal Type
- Financing Rounds
CAPP Medical General Information
Developer of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood. The company develops disruptive liquid non-invasive cancer detection technology using next generation DNA sequencing. Its technology allows for sensitivity and specificity without the need for patient specific optimizations.
Corporate Backed or Acquired
Discovery Tools (Healthcare)
- Palo Alto, CA
- United States
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
CAPP Medical Valuation & Funding
CAPP Medical Executive Team (1)
|Name||Title||Board Seat||Contact Info|
|Ashok Krishnamurthi||Chief Executive Officer|
CAPP Medical Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|